PolyPid to Present at the Investor Summit Virtual Conference on August 18, 2021
Aug 18, 2021 at 9:30 AM EDT
PETACH TIKVA, Israel, Aug. 09, 2021 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics, today announced that Executive Vice President and Chief Financial Officer Dikla Czaczkes Akselbrad will present a corporate overview at the Investor Summit Virtual Conference being held August 17 – 18, 2021.
Ms. Czaczkes Akselbrad will deliver her corporate presentation on August 18 at 9:30am ET.
Management will be available for one-on-one meetings to be held throughout the conference.
Investors can register here: Q3 Investor Summit Registration
